<DOC>
	<DOCNO>NCT02158689</DOCNO>
	<brief_summary>The accurate identification efficient management poor responder remain one enigmatic challenge assist reproductive technology ( ART ) . The investigator study compare letrozole/antagonist protocol hMG/antagonist protocol woman poor responder .</brief_summary>
	<brief_title>Comparison Treatment Modalities Poor Responders Undergoing IVF</brief_title>
	<detailed_description />
	<mesh_term>Menotropins</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Patients consider eligible poor ovarian responder accord Bologna criterion ( Ferraretti et al. , 2011 ) . Two three follow criterion essential order classify patient poor ovarian responder : advanced maternal age ( ≥40 year ) risk factor poor ovarian response ; poor ovarian response ( ≤3 oocytes conventional stimulation protocol ) ; abnormal ovarian reserve test ( antral follicle count , &lt; 7 follicle antiMullerian hormone , &lt; 1.1 ng/ml ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Poor responder</keyword>
	<keyword>letrozole</keyword>
	<keyword>human menopausal gonadotropin</keyword>
</DOC>